MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
NanoVibronix Retained Earnings 2011-2026 | NAOV
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings NanoVibronix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.8 M | -66.1 M | -62.4 M | -56.9 M | - | -38.3 M | -32.5 M | -28.4 M | -22.6 M | -19.7 M | -16.8 M | -14.2 M | -12.2 M | -10.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.9 M | -69.8 M | -34.7 M |
Quarterly Retained Earnings NanoVibronix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -76.9 M | -76 M | -72.3 M | -69.8 M | -68.4 M | -67.4 M | -66.7 M | -66.1 M | -65.3 M | -64.6 M | -63.5 M | -62.4 M | -60.3 M | -59.4 M | -58.1 M | -56.9 M | -54.5 M | -47.8 M | -47.6 M | -42.7 M | -42.7 M | -42.7 M | -42.7 M | -38.3 M | -38.3 M | -38.3 M | -38.3 M | -32.5 M | -32.5 M | -32.5 M | -32.5 M | -28.4 M | -28.4 M | -28.4 M | -28.4 M | -22.6 M | -22.6 M | -22.6 M | -22.6 M | -19.7 M | -19.7 M | -19.7 M | -19.7 M | -16.8 M | -16.8 M | -16.8 M | -16.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -16.8 M | -76.9 M | -42.7 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.22 | 5.21 % | $ 3.47 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 10.45 | 0.29 % | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.36 | -0.24 % | $ 600 M |  Israel |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.34 | -0.16 % | $ 1.16 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.27 | 9.21 % | $ 904 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 13.05 | 3.57 % | $ 1.96 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Establishment Labs Holdings
ESTA
|
-496 M | $ 65.01 | 2.41 % | $ 1.93 B |  Costa-rica |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 71.2 | 2.02 % | $ 105 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.68 | 4.61 % | $ 37 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.06 | 2.53 % | $ 151 M |  France |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 11.16 | 1.18 % | $ 302 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.45 | 0.16 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.17 | -0.91 % | $ 1.32 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 62.43 | 1.63 % | $ 3.41 B |  Britain |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.65 | 1.64 % | $ 882 M | Israel |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 4.36 | -1.13 % | $ 644 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 110.71 | 0.69 % | $ 193 B | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.74 | -0.71 % | $ 349 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.6 | 0.39 % | $ 153 M | Israel |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 269.48 | 3.15 % | $ 7.6 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.1 | 1.0 % | $ 701 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 32.75 | -0.27 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 176.12 | 3.94 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 33.74 | 2.99 % | $ 5.03 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.74 | 1.91 % | $ 154 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.21 | 0.58 % | $ 404 M | USA |